Orloff John J
EVP, Research & Development at ALEXION PHARMACEUTICALS INC
- Sold, on record
- $251k
- Dollars the filings state
- Form 4 sales
- 1
- Latest Jun 8, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ALEXION PHARMACEUTICALS INCEVP, Research & Development
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not statedJun 8, 2018 2018
Sold 2,115 shares at $118.53 ($251k)
Orloff John J, EVP, Research & Development
Sold 6.2% of holdings ($4M position)31,790 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (1)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 8, 2018 | Jun 12, 2018 | ALEXION PHARMACEUTICALS INC | EVP, Research & Development | Form 4 sale | 2,115 | $251k | 6.2% | Plan not stated | SEC |